You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 4, January 23, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Adverse Effects
 •Alert me on articles by topic

Daytime Sleepiness, Agonist Therapy, and Driving in Parkinson Disease

Cynthia L. Comella, MD

JAMA. 2002;287:509-511.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Frucht and colleagues1 proposed the unique association between treatment of Parkinson disease (PD) with 2 newer dopamine agonists and the occurrence of sudden onset of sleep, or sleep attacks. They described a series of 8 patients with PD treated with pramipexole or ropinirole who were involved in motor vehicle collisions because they fell asleep at the wheel. This small case series prompted grave concerns about the safety of prescribing the non-ergot dopamine agonists to patients with PD who drive. Recommended prescribing practices in many countries were altered.2-3 Multiple anecdotal and retrospective reports followed, all linking agonist therapy with excessive daytime sleepiness and sudden onset of sleep in patients with PD.4-7 Yet these reports did not systematically assess the frequency of daytime sleepiness in patients treated with other medications. This was a serious omission. Although levodopa initially was observed to cause transitory sleeplessness8, within 5 years . . . [Full Text of this Article]

Author Affiliation: Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill.


RELATED LETTER

Daytime Sleepiness, Agonist Therapy, and Driving in Parkinson Disease
Cynthia L. Comella
JAMA. 2002;287(4):509-511.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease: A Survey by the Canadian Movement Disorders Group
Douglas E. Hobson, Anthony E. Lang, W. R. Wayne Martin, Ajmal Razmy, Jean Rivest, and Jonathan Fleming
JAMA. 2002;287(4):455-463.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Excessive daytime sleepiness and subsequent development of Parkinson disease
Abbott et al.
Neurology 2005;65:1442-1446.
ABSTRACT | FULL TEXT  

Quantitative assessment of driving performance in Parkinson's disease
Wood et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:176-180.
ABSTRACT | FULL TEXT  

Sudden-Onset Sleep in Parkinson Disease
Frucht and Comella
JAMA 2002;287:2076-2077.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.